Scientific Program

Scientific Program

The 13th World Stroke Congress will bring the latest science, clinical trials and guidelines to
stroke prevention, treatment, rehabilitation, and support, from every part of the globe.

The preliminary program of WSC 2021 is online. Click on the button below to see all the confirmed sessions.

Program at a Glance

*Updated as of 26 May 2021.

** The program is subject to change.

Program Highlights

28 October 2021, 12:00 – 13:30 CET

Opening, Awards and Late Breaking Clinical Trials

WSO Award for Contributions to Clinical Research

WSO Award for Stroke Services

WSO President’s Award

Late Breaking Clinical Trials

 

28 October 2021, 19:15 – 20:45 CET

Prehospital Stroke Care

Chair: James Grotta, USA

Latest Trial Results from BEST-MSU 

Speaker: James Grotta, USA

PRESTO Consortium: New Studies Going Forward

Speaker: TBC

Prehospital Triage for Large Vessel Occlusion

Speaker: Alexandra Czap, USA

Prehospital Strategies for Brain Hemorrhage Management 

Speaker: Stephen Davis, Australia

Implementation Challenges in Different Countries 

Speaker: TBC

 

29 October 2021, 11:30 – 13:00 CET

Stroke in Low to Middle Income Countries

Chairs:

Norlinah Ibrahim, Malaysia

Mayowa Owolabi, Nigeria

Overview of the Lancet Commission

Speaker: Mayowa Owolabi, Nigeria

The Changing World Landscape in Stroke Epidemiology

Speaker: TBC

Economic Burden of Stroke

Speaker: Ajay Mahal, Australia

Realistic and Aspirational Stroke Prevention Goals

Speaker: Valery Feigin, New Zealand

Challenges in Delivering Comprehensive Stroke Care

Speaker: Jeyaraj Pandian, India

28 October 2021, 8:00 – 9:30 CET

COVID Thrombosis and Stroke

How COVID 19 Impacted Stroke Services

Does COVID-19 Really Cause Stroke, What Types and Why?

COVID Vaccine Related Thrombosis

 

28 October 2021, 8:00 – 9:30 CET

Neuroimaging 

CT scan for Treatment Selection in Acute Ischemic Strokes

CT Perfusion in Acute Ischemic Stroke: Interpretation and Pitfalls

MRI in Acute Ischemic Stroke Within and Beyond the Established Time Windows

Portable MRI: What’s Possible Now and What’s Coming

 

28 October 2021, 10:00 – 11:30 CET

Stroke Action Plans Around the World

European Stroke Action Plan

American Stroke Association 2030 Goals

China’s National Stroke Plan

Africa’s National Stroke Plan

 

28 October 2021, 15:45 – 17:15 CET

Emerging Treatments for Brain Hemorrhage

Pro-coagulants in Hyperacute Phase of ICH

Stereotactic Minimally Invasive Evacuation 

Upcoming Treatment Approaches from Bench to Bedside

Blood Pressure Control after ICH

 

28 October 2021, 17:45 – 19:15 CET

Enhancing Stroke Care with Artificial Intelligence

Automated Evaluation of Acute Stroke Imaging

Clinical Decision Tools for Hospitalized Stroke Care

Neurocritical Care and AI

Stroke Recovery – ENIGMA 

Imaging, AI and Prediction of Recovery

 

29 October 2021, 8:00 – 9:30 CET

Latest Advances in Recovery and Rehabilitation

Prognostic Modeling and Algorithms for Arm Impairment

Vagal Nerve Stimulation for Motor Recovery

Telerehabilitation

Cell-based Regenerative Therapies

 

29 October 2021, 8:00 – 9:30 CET

Neuropsychiatric Symptoms of Stroke: An Update

Psychological and Psychiatric Triggers and Risk Factors for Stroke

Post-stroke Delirium

Post-stroke Depression, Apathy and Anxiety

Neuropsychiatric Symptoms of CADASIL

 

29 October 2021, 10:00 – 11:30 CET

Cerebral Small Vessel Diseases and Vascular Cognitive Impairment: A New WSO Task Force on Major Understudied Brain Conditions

Global Pandemics Require a Global Taskforce: The Aims of the cSVD & VCI Taskforce in WSO

cSVD/VCI in Developing Countries: What do we Know, What do we Need to Learn?

Neurology and Neuroradiology Collaborations to Detect cSVD

Lessons from Cardiology to Reduce cSVD/VCI Risks

 

29 October 2021, 10:00 – 11:30 CET

Transient Ischemic Attacks: Where are we ?  

Models of TIA Care

New Diagnostic Tools

Risk of Transient Neurological Symptoms

Treatment Update

 

29 October 2021, 15:15 – 16:45 CET

Vascular Cognitive Impairment

Vascular Cognitive Impairment: When and How to Screen in Clinical Practice?

Predicting Dementia After Stroke

Biomarkers of Vascular Cognitive Impairment

Mixed Dementia: Inter-relationships of Vessel and AD Pathology

 

29 October 2021, 17:15 – 18:45 CET

Big Data and Public Health Initiatives

COVID-19 Registry Datasets

GWTG

Eastern Europe

Clinical Application of Large Datasets

 

29 October 2021, 17:15 – 18:45 CET

Future Directions in Stroke Therapy Development

Intra-arterial Therapy Development in Stroke Pig Models

Molecular Imaging

The Potential Therapeutic Applications of Microvessicles

Emerging Concepts from Basic Science

Gut-brain Axis and NeuroInflammation